1. Home
  2. NMRA vs AEHR Comparison

NMRA vs AEHR Comparison

Compare NMRA & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • AEHR
  • Stock Information
  • Founded
  • NMRA 2019
  • AEHR 1977
  • Country
  • NMRA United States
  • AEHR United States
  • Employees
  • NMRA N/A
  • AEHR N/A
  • Industry
  • NMRA
  • AEHR Electrical Products
  • Sector
  • NMRA
  • AEHR Industrials
  • Exchange
  • NMRA Nasdaq
  • AEHR Nasdaq
  • Market Cap
  • NMRA 287.6M
  • AEHR 339.6M
  • IPO Year
  • NMRA 2023
  • AEHR 1997
  • Fundamental
  • Price
  • NMRA $1.01
  • AEHR $7.29
  • Analyst Decision
  • NMRA Buy
  • AEHR Hold
  • Analyst Count
  • NMRA 8
  • AEHR 2
  • Target Price
  • NMRA $10.14
  • AEHR $12.00
  • AVG Volume (30 Days)
  • NMRA 1.2M
  • AEHR 828.4K
  • Earning Date
  • NMRA 03-03-2025
  • AEHR 04-08-2025
  • Dividend Yield
  • NMRA N/A
  • AEHR N/A
  • EPS Growth
  • NMRA N/A
  • AEHR 6.35
  • EPS
  • NMRA N/A
  • AEHR 0.75
  • Revenue
  • NMRA N/A
  • AEHR $50,735,000.00
  • Revenue This Year
  • NMRA N/A
  • AEHR $5.83
  • Revenue Next Year
  • NMRA N/A
  • AEHR $23.36
  • P/E Ratio
  • NMRA N/A
  • AEHR $9.68
  • Revenue Growth
  • NMRA N/A
  • AEHR N/A
  • 52 Week Low
  • NMRA $0.95
  • AEHR $7.08
  • 52 Week High
  • NMRA $17.19
  • AEHR $21.44
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.42
  • AEHR 29.16
  • Support Level
  • NMRA $1.12
  • AEHR $8.69
  • Resistance Level
  • NMRA $1.23
  • AEHR $9.37
  • Average True Range (ATR)
  • NMRA 0.10
  • AEHR 0.53
  • MACD
  • NMRA 0.04
  • AEHR -0.05
  • Stochastic Oscillator
  • NMRA 2.18
  • AEHR 7.66

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

Share on Social Networks: